CA2461291A1 - Inhibition de la production d'exoproteines a l'aide de compositions aromatiques - Google Patents

Inhibition de la production d'exoproteines a l'aide de compositions aromatiques Download PDF

Info

Publication number
CA2461291A1
CA2461291A1 CA002461291A CA2461291A CA2461291A1 CA 2461291 A1 CA2461291 A1 CA 2461291A1 CA 002461291 A CA002461291 A CA 002461291A CA 2461291 A CA2461291 A CA 2461291A CA 2461291 A1 CA2461291 A1 CA 2461291A1
Authority
CA
Canada
Prior art keywords
active ingredient
exoprotein
set forth
group
absorbent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002461291A
Other languages
English (en)
Inventor
Rae Ellen Syverson
Richard A. Proctor
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kimberly Clark Worldwide Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/969,299 external-priority patent/US20030135173A1/en
Priority claimed from US09/969,218 external-priority patent/US7026354B2/en
Priority claimed from US09/969,391 external-priority patent/US7022333B2/en
Application filed by Individual filed Critical Individual
Publication of CA2461291A1 publication Critical patent/CA2461291A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/216—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with other specific functional groups, e.g. aldehydes, ketones, phenols, quaternary phosphonium groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/45—Mixtures of two or more drugs, e.g. synergistic mixtures
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/80—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special chemical form
    • A61L2300/802—Additives, excipients, e.g. cyclodextrins, fatty acids, surfactants

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Materials Engineering (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
  • Materials For Medical Uses (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)

Abstract

L'invention concerne des articles absorbants et non absorbants. Ces articles comprennent une quantité efficace d'un composé aromatique inhibiteur destiné à inhiber sensiblement la production d'exotoxines par des bactéries gram positif. Les composés aromatiques inhibiteurs de la présente invention sont représentés par la formule générale (I), dans laquelle R?1¿ est sélectionné dans le groupe composé de H, (a), -OR?5¿, -R?6¿C(O)H, -R?6¿OH, -R?6¿COOH, -OR?6¿OH, -OR?6¿COOH, -C(O)NH¿2?, et NH¿2? et les sels de ceux-ci; R?5¿ est un fragment hydrocarbyle aliphatique monovalent saturé ou non saturé; R?6 ¿est un fragment hydrocarbyle aliphatique divalent saturé ou non saturé; R?7 ¿est un fragment hydrocarbyle aliphatique trivalent saturé ou non saturé; R?8¿ est un fragment hydrocarbyle aliphatique monovalent saturé ou non saturé substitué ou non substitué pouvant ou ne pouvant pas être interrompu par des hétéroatomes; R?2¿, R?3¿ et R?4¿ sont indépendamment sélectionnés dans le groupe composé de H, OH, COOH, et -C(O)R?9¿; et R?9 ¿est hydrogène ou un fragment hydrocarbyle aliphatique monovalent saturé ou non saturé.
CA002461291A 2001-10-02 2002-09-09 Inhibition de la production d'exoproteines a l'aide de compositions aromatiques Abandoned CA2461291A1 (fr)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US09/969,299 US20030135173A1 (en) 2001-10-02 2001-10-02 Inhibition of exoprotein production in absorbent articles using aromatic compositions
US09/969,391 2001-10-02
US09/969,218 2001-10-02
US09/969,218 US7026354B2 (en) 2001-10-02 2001-10-02 Aromatic compositions for the inhibition of exoprotein production from gram positive bacteria
US09/969,299 2001-10-02
US09/969,391 US7022333B2 (en) 2001-10-02 2001-10-02 Inhibition of exoprotein production in non-absorbent articles uisng aromatic compositions
PCT/US2002/028756 WO2003030953A1 (fr) 2001-10-02 2002-09-09 Inhibition de la production d'exoproteines a l'aide de compositions aromatiques

Publications (1)

Publication Number Publication Date
CA2461291A1 true CA2461291A1 (fr) 2003-04-17

Family

ID=27420759

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002461291A Abandoned CA2461291A1 (fr) 2001-10-02 2002-09-09 Inhibition de la production d'exoproteines a l'aide de compositions aromatiques

Country Status (9)

Country Link
EP (1) EP1432459A1 (fr)
JP (1) JP2005523239A (fr)
KR (1) KR100918887B1 (fr)
AR (1) AR037505A1 (fr)
AU (1) AU2002336472B2 (fr)
BR (1) BR0212679A (fr)
CA (1) CA2461291A1 (fr)
MX (1) MXPA04002474A (fr)
WO (1) WO2003030953A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102009007799B4 (de) * 2009-02-06 2010-10-14 ITM Isotopen Technologien München AG Molekül zur Funktionalisierung eines Trägers, Bindung eines Radionuklids an den Träger und Radionuklidgenerator zur Herstellung des Radionuklids sowie Herstellungsverfahren
DK3223764T3 (da) * 2014-11-27 2023-11-20 Univ Yeditepe Antimikrobielle og antivirale hygiejneprodukter
JP6780123B2 (ja) * 2016-10-09 2020-11-04 深▲せん▼優麗康生物技術有限公司Ｓｈｅｎｚｈｅｎ Ｅｕｌｉｋａｎ Ｂｉｏｔｅｃｈｎｏｌｏｇｙ Ｃｏ．， Ｌｔｄ． 静菌剤配合の膣用組成物の調製への用途及び膣用組成物

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3317376A (en) * 1963-02-12 1967-05-02 Robert I Schattner Germicidal fabric
IL55214A (en) * 1978-07-25 1981-07-31 Abic Ltd Antibacterial compositions containing trimethoprim and other ingredients
DE3204124A1 (de) * 1982-02-06 1983-08-18 Bayer Ag, 5090 Leverkusen Antimykotische tampons mit hoher wirkstoff-freisetzung
US4560549A (en) * 1983-08-24 1985-12-24 Lever Brothers Company Method of relieving pain and inflammatory conditions employing substituted salicylamides
GB2186486B (en) * 1986-02-13 1989-11-08 Smith & Nephew Ass Antibacterial dressing
US5180749A (en) * 1989-08-22 1993-01-19 Sterling Winthrop, Inc. Antimicrobial composition
US5476455A (en) * 1993-01-11 1995-12-19 Silber; Arthur L. Toxicity resistant tampon structure
DE4411664A1 (de) * 1994-04-05 1995-10-12 Beiersdorf Ag Neue desodorierende und antimikrobielle Zusammensetzungen zur Verwendung in kosmetischen oder topischen Zubereitungen
JPH07289575A (ja) * 1994-04-27 1995-11-07 Okamoto Ind Inc 香料添加コンドーム及びコンドームへの香料添加方法
US5668097A (en) * 1994-08-12 1997-09-16 The Procter & Gamble Company Uncomplexed cyclodextrin solutions for odor control on inanimate surfaces
DE4434781A1 (de) * 1994-09-29 1996-04-04 Beiersdorf Ag Verwendung von Fettsäureestern zur Bekämpfung von Superinfektionen
JP4044959B2 (ja) * 1995-06-07 2008-02-06 キンバリー クラーク ワールドワイド インコーポレイテッド 吸収性物品中のエクソプロテインの阻害
JPH09108257A (ja) * 1995-10-23 1997-04-28 Shiyouichi Masugi 蓄光性クリーム及びラテックス製コンドーム
GB9612595D0 (en) * 1996-06-15 1996-08-21 Smithkline Beecham Plc Composition
JP2001502302A (ja) * 1996-09-19 2001-02-20 アメリカン・ホーム・プロダクツ・コーポレイション 尿失禁を治療する方法
CA2287451C (fr) * 1997-04-18 2014-06-10 Sean Farmer Utilisation topique de spores de bacilles probiotiques pour prevenir ou traiter les infections microbiennes
KR20010013377A (fr) * 1997-06-04 2001-02-26 데이비드 엠 모이어 Compositions antimicrobiennes comprenant un analogue de l'acide benzoique et un sel metallique
US6353004B1 (en) * 1997-07-14 2002-03-05 Adolor Coporation Peripherally acting anti-pruritic opiates
ES2176951T3 (es) * 1998-01-28 2002-12-01 Procter & Gamble Polimeros absorbentes antimicrobianos que forman hidrogel.
EP1024808A1 (fr) * 1998-04-11 2000-08-09 Errekappa Euroterapici S.p.a. Preparations pharmaceutiques a base de sels de ketoprofene hydrosoluble et applications correspondantes
FR2777783A1 (fr) * 1998-04-24 1999-10-29 Innothera Lab Sa Association pharmaceutique d'imidazoles pour le traitement local des vulvo-vaginites infectieuses et des vaginoses
EP1082149B2 (fr) * 1998-05-29 2011-12-14 Kimberly-Clark Worldwide, Inc. Meilleure absorption des odeurs par des polymeres naturels et de synthese

Also Published As

Publication number Publication date
JP2005523239A (ja) 2005-08-04
BR0212679A (pt) 2005-04-12
AR037505A1 (es) 2004-11-17
WO2003030953A1 (fr) 2003-04-17
KR20040044950A (ko) 2004-05-31
EP1432459A1 (fr) 2004-06-30
KR100918887B1 (ko) 2009-09-23
MXPA04002474A (es) 2004-05-31
AU2002336472B2 (en) 2007-08-23

Similar Documents

Publication Publication Date Title
EP0846005B1 (fr) Inhibition d'exoproteines dans un article absorbant
ZA200402226B (en) Inhibition of exoproteins using isoprenoids
US6821999B2 (en) Methods for inhibiting the production of TSST-1
US20060135616A1 (en) Aromatic compositions for the inhibition of exoprotein production from gram positive bacteria
US20100274071A1 (en) Aromatic Compositions As Inhibitors Of Exoprotein Production In Non-Absorbent Articles
US20080096850A1 (en) Methods for inhibiting the production of tsst-1
AU2002336472B2 (en) Inhibition of exoprotein production using aromatic compositions
US7118759B2 (en) Absorbent articles containing additives
US20080033382A1 (en) Inhibition of exoprotein production in absorbent articles using aromatic compositions
AU2002336472A1 (en) Inhibition of exoprotein production using aromatic compositions
AU2002228597B2 (en) Inhibition of exoprotein production from grampositive bacteria
US8084046B2 (en) Inhibition of exoprotein production in absorbent articles using isoprenoids
AU2002326861B2 (en) Inhibition of exoproteins using isoprenoids
US7348023B2 (en) Absorbent articles containing additives
US20060067990A1 (en) Absorbent articles for inhibiting the production of exoproteins
CA2461197A1 (fr) Inhibition des exoproteines au moyen d'isoprenoides
AU2002326861A1 (en) Inhibition of exoproteins using isoprenoids
AU2005292655A1 (en) Non-absorbent and absorbent articles for inhibiting the production of exoproteins

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued